OFT to investigate heartburn drug competition

OFT to investigate heartburn drug competition

Household goods giant Reckitt Benckiser has been accused of abusing its dominant position in the supply of heartburn medicines to the NHS.

You need to be signed in to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here